News
Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...
Hosted on MSN1mon
Two-phase vaccination can boost the immune system against cancerIn another approach, the vaccine, which is protein-based or peptide-based, contains only the protein of the tumor antigen or at least parts of it. This synthetic method is faster, cheaper and less ...
These therapies involve programming the T-cell receptor (TCR) of T cells to recognize a specific peptide, or antigen, found on tumor cells. There are many efforts underway to identify the most ...
In the field of cancer immunotherapy, unconventional T cells (UCTs) and Chimeric Antigen Receptor (CAR) T cells have emerged as promising areas of research ...
Trained immunity is a form of innate immune cell memory that is being developed as a novel immunotherapeutic approach for cancer treatment.
For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...
9d
Pharmaceutical Technology on MSNEnterome to advance EO2463 immunotherapy with $19m fundingEnterome has secured $19m in new private funding to progress its EO2463 OncoMimics immunotherapy, targeting iNHL.
During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results